First-line therapy for chronic phase CML: selecting the optimal BCR-ABL1-targeted TKI

Giuseppe Saglio, Elias Jabbour

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'First-line therapy for chronic phase CML: selecting the optimal BCR-ABL1-targeted TKI'. Together they form a unique fingerprint.

Medicine & Life Sciences